In addition, we also investigated critical molecular events such as KRAS, BRAF and PIK3CA mutations and MSI status, all of which have been associated with colorectal cancer prognosis in order to adjusted our results [52–54]. The gene discussed is BRAF; the disease is colorectal cancer.